Page 421 - Si Reporter

Stock Market Highlights, May 24: Indices end flat after hitting record highs; Nifty below 23,000

Stock market highlights on Friday, May 24: Among sectors, the Nifty Bank, and Private Bank indices added 0.4 per cent each

Small-cap firm Cheviot to buyback shares worth Rs 31.5 cr at Rs 1,800/ sh

Cheviot buyback news: Shares of Cheviot Co declined 5.3 per cent to Rs 1,476 apiece on the BSE on Friday

PSP Projects slips 4% after Q4 profit plunges 66%; check details here

PSP Projects stock fell as much as 4.27 per cent to hit an intraday low of Rs 656.20 per share

This small-cap stock dropped 7% in trade on May 24; dividend announced

Landmark Cars' net profit dropped over 54 per cent to about Rs 11 crore in the fourth quarter of financial year 2024 (Q4FY24), from Rs 24.3 crore in the same quarter previous fiscal (Q4FY23)

Bayer CropScience stock declines 6% on Friday post Q4; Check details here

Bayer CropScience's revenue slipped 19.5 per cent on a year-on-year (Y-o-Y) basis to Rs 792 crore as opposed to Rs 983 crore in the same quarter a year ago

Finolex Cables stock hits record high; zooms 19% on healthy Q4 results

Finolex Cables stock update: The company's board also recommended a dividend of 400% i.e. Rs 8 per share on face value of Rs 2.

JK Lakshmi Cement shares rally 7% on healthy Q4; up 15% in last one year

The surge in JK Lakshmi Cement share was fuelled by robust Q4FY24 results, which came in line with street estimates

Adani Enterprises stock at 16-mth high; here's what aided the recent gains

Adani Enterprises stock update: The stock was up 2 per cent in Friday's intra-day deals after the company said its board will meet on 28 May to consider fund raise.

Emkay Global sees 31% downside in Go Digit stock, gives 'Sell' rating

Go Digit stock: Go Digit's valuation at FY26E P/E of 49.6x and P/B of 5.9x seems to be building-in an optimistic outlook and ignoring the challenges, Emkay Global said

Stock Market Highlights, May 23: Indices end at record highs! Sensex soars 1197 pts, Nifty nears 23K

Stock market LIVE updates on Thursday, May 23, 2024: In the broader markets, the S&P BSE MidCap index hit a new high of 43,442.5, while the S&P BSE SmallCap index touched a new lifetime high of 48,229

Adani Group stocks rally; Enterprises surges 8%, Ports, Power hit new high

Report say Adani Enterprises may replace Wipro in the benchmark Sensex index. This may lead to inflows worth Rs 1,000 crore in the stock

Sun Pharma hits over 3 month low; slips 5% in strong market post Q4 results

The management guided for high single digit revenue growth in FY25 factoring in the impact of US site compliance issues.

This PSU defense stock to turn ex-split on Friday; zooms 54% in 8 days

Bharat Dynamics had fixed May 24, 2024 as the record date for the purpose of determining the eligibility of shareholders for sub-division/ split of face value of equity shares from Rs 10 to Rs 5 each.

Go Digit debuts on a quiet note; lists at 5% premium to issue price

Post listing, the Go Digit stock touched a high of Rs 294.75, commanding a 8 per cent premium to its issue price of Rs 272 per share on the NSE.

Star Cement falls 5% on tepid March quarter; profit drops over 10%

Star Cement's net profit dropped 10.3 per cent to Rs 87 crore from Rs 96 crore year-on-year (Y-o-Y), while revenue rose 9.2 per cent to Rs 913 crore compared to Rs 829 crore in the same period last ye

GMM Pfaudler slips 5% on weak Q4 performance; Rs 1 dividend announced

GMM Pfaudler's consolidated net profit dropped 14 per cent to Rs 28.7 crore in Q4FY24, from Rs 33.3 crore in the same quarter a year ago (Q4FY23)

PSBs on a roll after RBI doles out Rs 2 trn dividend to govt; index up 2%

At 10:30 am; Nifty PSU Bank index, the top gainer among sectoral indices, was up 2.5%, as compared to 0.42% rise in the Nifty 50, while Nifty Bank and Nifty Private Bank index are up 1%

Gland Pharma surges 11% amidst stellar Q4 results; profits grow two fold

On Wednesday, Gland Pharma reported a two fold jump or 145 per cent increase in consolidated net profit, reaching Rs 192.4 crore for the January-March period of FY24

Strides rallies 9% intraday, hits over 3 year high on healthy Q4 results

Strides Pharma stock price: For FY25, Strides said revenue may grow at 12-15 per cent Y-o-Y and the significant growth will come in H2FY25 based on targeted product launches globally

Cipla rallies 4% on US FDA approval to market Lanreotide injection

The approval for the generic version of Lanreotide Acetate is in line with Cipla's growth strategy in the complex product segment and will strengthen Cipla's position in the US market.